EN
/
JP
News
About Us
About Us
Philosophy/Policy
Board of Directors
History
Company Information
Corporate Governance
Partner
Close
Business Strategy
Business Strategy
Business Model
Life Cycle Management Strategy
Close
Technology
Technology
SLC Transporters
LAT1 Inhibitors
Close
Pipeline
Pipeline
Development Status
Biliary Tract Cancer
Multiple Sclerosis
Other Pipelines
Close
Clinical Trials
Clinical Trials
Biliary Tract Cancer Phase III
Biliary Tract Cancer Investigator-Initiated Clinical Trial
JPH034 Phase 1
Close
IR
IR
IR News
Top Message
Disclosure Policy
Financial Highlights
IR Calendar
IR Library
Financial Results
Presentation Materials
IR Materials
Stock Information
Stock Overview
General Meeting of Shareholders
Disclaimer
Close
Contact
EN
/
JP
Close
Top
＞
News Lists
News Lists
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2022.12.23
We are pleased to announce J-Pharmaʼs lead oncology product candidate, Nanvuranlat will feature at the upcoming ASCO Gastrointestinal Cancers Symposium, to be held in San Francisco on 19-21 January 2023
2022.12.23
J-Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022.05.19
Life Science Review Magazine named J-Pharma as a Top 10 Bio Tech Startup in APAC 2022
2022.04.21
J-Pharma Announces FDA Orphan Drug Designation for JPH203 for the Treatment of Biliary Tract Cancer
2022.01.05
J-Pharma to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021.11.22
Participation in the Startup City Acceleration Program
2021.07.30
J-Pharma Raises 600 Million JPY from JIC Venture Growth Investments (VGI)
2021.03.16
Organization and Personnel Changes
2021.03.04
J-Pharma raises 500 Million JPY from Ohara Pharmaceutical Co., Ltd.
2021.01.07
J-Pharma Raises 500 Million JPY from Eights Roads Ventures & F-Prime Capital Partners
1
2
3
4
5
6
7
8
